Brief: Biohaven Reports Second Quarter 2025 Financial Results
11/08/2025 12:09
Aug 11 (Reuters) - Biohaven Ltd BHVN.N: BIOHAVEN Q2 OPERATING EXPENSES USD 211.701 MILLION BIOHAVEN Q2 PROFIT FROM OPERATIONS USD -211.701 MILLION BIOHAVEN Q2 NET INCOME USD -198.147 MILLION BIOHAVEN Q2 BASIC EPS USD -1.94 Source text: ID:nPn7d2P9Da Further company coverage: BHVN.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biohaven
See all newsU.S. STOCKS ON THE MOVE-Quest Diagnostics, Tractor Supply, Dutch Bros
Brief: Biohaven - FDA Accepts Biohaven NDA Resubmission For Vyglxia (Troriluzole) In SCA
Biohaven jumps as FDA takes second look at brain disorder drug
Brief: Biohaven Enters Strategic Licensing Agreement With Ono Pharma
Ono Pharma Announces An Exclusive License Agreement With Biohaven To Develop And Commercialize Igg Degraders In Japan, South Korea, Taiwan, And Asean